Last Updated : Thursday, April 9, 2020 21:04:59

Tag Archives: Special Economic Zone

CADILA HEALTH gets USFDA nod to sell tablets to treat cancer conditions

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Cadila Group’s – Cadila Healthcare Ltd said of having got final approval from USFDA (US Food and Drugs Administration) for tablet to treat several types of cancer. In a press-release titled,

CADILA HEALTH gets USFDA nod to market tablets to treat Parkinson’s disease

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) got USFDA (US Food and Drugs Administration) nod to market tablet to treat Parkinson’s disease or Parkinson’s like symptoms. In a company press-release titled, “Zydus receives

INDIA HOME MIN chairs ISLAND DEVELOPMENT meet

NEW DELHI | RAJKOT – In a press-release issued by Press Information Bureau (PIB) of India, press & publicity arm of Indian Government, it read of Union Minister of Home Affairs, Amit Shah having chaired sixth meeting of the Island Development Agency (IDA) with a view to focus on Green Development of the islands surrounding

SEZ policy revamp soon, BABA KALYANI Report recommendations reviewed

NEW DELHI | RAJKOT – In a press-release as issued by Press Information of Bureau (PIB) of India – press & publicity arm of Indian Government, it said of Commerce & Industries and Railways Minister Piyush Goyal chaired a meeting on 9th January, 2020 in New Delhi to review the remaining recommendations of the Baba

Zydus Cadila gets USFDA nod to market sedative/hypnotic (sleep disorder treatment drug)

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses, Ahmedabad headquartered Dr. Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat insomnia (sleep related disorders) The press release submitted by the company

Zydus Cadila gets USFDA nod to market drug to treat excess iron levels in human blood

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Exchanges on Tuesday, Ahmedabad headquartered and Pankaj Patel owned Cadila Healthcare (Zydus Cadila Group) said of having got US Food and Drugs Administration nod to market drug to treat excess iron levels in human blood. Zydus Cadila has received the tentative

Zydus Cadila gets US FDA nod to market osteoporosis, ortho treatment drug

MUMBAI | AHMEDABAD | RAJKOT – Dr Pankaj Patel led and Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) has received final approval from the US regulators to market ortho treatment medicine, the company said in a press release submitted to the Indian Bourses, today. Zydus Cadila has received the final approval from the USFDA

Zydus Cadila gets US FDA nod to market tablets for diabetic care

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Dr Pankaj Patel led Zydus Cadila group (Cadila Healthcare Ltd.) said of having got approval from US FDA (Food & Drugs Administration) to market Sitagliptin Tablets in dosage value of 25 mg (milligram), 50 mg and 100 mg.

Zydus Cadila gets USFDA nod to market anti-viral drug

AHMEDABAD | MUMBAI | RAJKOT – Dr Pankaj Patel led Zydus Cadila Group got US FDA (Food and Drugs Administration) nod to market anti-viral drug Acyclovir Sodium Injection in composition of 500 mg and 1,000 mg, Cadila Healthcare Ltd said today, in a press release submitted to the Exchanges in India. Zydus Cadila has received

Zydus Cadila gets USFDA nod to market anti-bacterial drug to cure respiratory, skin, ear and sexually transmitted disease

AHMEDABAD | MUMBAI | RAJKOT – Zydus Cadila (Cadila Healthcare Ltd) has received the final approval from the USFDA to market Azithromycin for Oral Suspension USP (US RLD – Zithromax), 100 mg/5 mL and 200 mg/5 mL, the company said in the press release submitted to Exchanges in India on Wednesday. This medication contains Azithromycin, a

Zydus Cadila gets USFDA nod to market impotence treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the exchanges in India, Cadila Healthcare Ltd said of having got tentative approval to market drug to cure erectile dysfunction. Zydus Cadila has received the tentative approval from the USFDA to market Vardenafil Hydrochloride Tablets (US RLD-Levitra) in the strengths of 2.5 mg, 5

Zydus Cadila gets USFDA nod to market injection to cure liver injury

AHMEDABAD | MUMBAI | RAJKOT – Cadila Healthcare Ltd in a regulatory filing submitted to the Exchanges in India said of having got US FDA (Food & Drug Administration) nod to market an injection to cure liver injury. Zydus Cadila has received the final approval from the USFDA to market Acetylcysteine Injection (US RLD –

Zydus Cadila cracks one more USFDA approval to cure High Blood Pressure

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to exchanges in India on Friday, Cadila Healthcare Ltd said of getting one more approval from US FDA (Food & Drug Administration) to market tablets to cure high blood pressure and prevent heart failure. Zydus Cadila has received the final approval from the USFDA

USFDA Approvals raining for Zydus Cadila, clicks one more, to market joint-pain (arthritis) treatment drug

AHMEDABAD | MUMBAI | RAJKOT – It seems US FDA (Food & Drug Administration) approvals are raining for Zydus Cadila (Cadila Healthcare Ltd) as the company has been constantly submitting USFDA approval filings on one or the other day in the month of July. Zydus Cadila has one more to its portfolio and this time

Zydus Cadila gets USFDA nod to market four new drugs

AHMEDABAD | MUMBAI | RAJKOT – Zydus Cadila (Cadila Healthcare Ltd) got US FDA (Food & Drugs Administration) nod to market four drugs, this drugs are primely used to treat mental moods/conditions & depression, diet & exercise equivalent to cure diabetic disorders, injection to treat fungal infections and a drug to treat skin allergies, the

Oriental Carbon kicks-off Phase-2 production at MUNDRA facility

MUNDRA | KOLKATTA | MUMBAI | RAJKOT – In a regulatory filing submitted to the exchanges in India, Oriental Carbon & Chemicals Ltd said of having commenced commercial production with effect from July 16, 2018 – Monday at company’s Kutch (Mundra) facility. Company has commissioned / started the commercial production today i.e. on July 16,

Do NOT follow this link or you will be banned from the site!